                               SEQUENCE LISTING

<110> NOVARTIS AG
 
<120> METHODS FOR THE TREATMENT OF OSTEOARTHRITIS

<130> PAT059120-WO-PCT

<140>
<141>

<150> 63/192,348
<151> 2021-05-24

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 219
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Ile Pro Ala Glu Cys Thr Thr Ile Tyr Asn Arg Gly Glu His Thr Ser 
1               5                   10                  15      


Gly Met Tyr Ala Ile Arg Pro Ser Asn Ser Gln Val Phe His Val Tyr 
            20                  25                  30          


Cys Asp Val Ile Ser Gly Ser Pro Trp Thr Leu Ile Gln His Arg Ile 
        35                  40                  45              


Asp Gly Ser Gln Asn Phe Asn Glu Thr Trp Glu Asn Tyr Lys Tyr Gly 
    50                  55                  60                  


Phe Gly Arg Leu Asp Gly Glu Phe Trp Leu Gly Leu Glu Lys Ile Tyr 
65                  70                  75                  80  


Ser Ile Val Lys Gln Ser Asn Tyr Val Leu Arg Ile Glu Leu Glu Asp 
                85                  90                  95      


Trp Lys Asp Asn Lys His Tyr Ile Glu Tyr Ser Phe Tyr Leu Gly Asn 
            100                 105                 110         


His Glu Thr Asn Tyr Thr Leu His Leu Val Ala Ile Thr Gly Asn Val 
        115                 120                 125             


Pro Asn Ala Ile Pro Glu Asn Lys Asp Leu Val Phe Ser Thr Trp Asp 
    130                 135                 140                 


His Lys Ala Lys Gly His Phe Asn Cys Pro Glu Gly Tyr Ser Gly Gly 
145                 150                 155                 160 


Trp Trp Trp His Asp Glu Cys Gly Glu Asn Asn Leu Asn Gly Lys Tyr 
                165                 170                 175     


Asn Lys Pro Arg Ala Gln Ser Lys Pro Glu Arg Arg Arg Gly Leu Ser 
            180                 185                 190         


Trp Lys Ser Gln Asn Gly Arg Leu Tyr Ser Ile Lys Ser Thr Lys Met 
        195                 200                 205             


Leu Ile His Pro Thr Asp Ser Glu Ser Phe Glu 
    210                 215                 


